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Abstract Although nitric oxide (NO) has been known to 
generate Snltroso-thiols (RSNOs), dynamic aspects of their 
metabolism remain to be elucidated. The present work reports 
the reactivity of Snitroso-glutathione (GS-NO) with various 
compounds with reducing activity. Kinetic analysis revealed that 
among various reagents tested, ascorbic acid showed a potent 
activity to decompose GS-NO to glutathione and oxidized 
products of NO. During the reaction of GS-NO and ascorbic 
acid, monodehydroascorbate was found to appear as an 
intermediate. These results suggest that ascorbic acid might be 
an important modulator for RS-NO metabolism. 
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1. Introduction 
Nitric oxide (NO) has received much attention not only as 
ar endothelium-derived relaxing factor (EDRF) [l] but also as 
a icy molecule for a variety of biological events. NO exerts its 
bi<rlogical function through interaction with a number of bio- 
molecules, such as heme iron, nonheme iron [2], oxygen [3,4] 
and superoxide anion [5]. NO also generates S-nitroso-thiols 
(RS-NOs) including S-nitroso-glutathione (GS-NO) [6,7]. In 
th s context, Stamler et al. [8,9] reported that plasma and 
br’mchial lavage fluid from healthy human contained about 
7 tnd 0.3 PM of RS-NO and GS-NO, respectively. 
RS-NO also exhibits various activities attributed to NO. In 
fa,t, GS-NO, S-nitrosocysteine and S-nitroso-albumin have 
bezn reported to possess EDRF-like activity [l&13]. Ignarro 
[ld] and Craven [15] suggested that NO released from RS- 
Nc 1s was responsible for their EDRF-like action, On the other 
hand, Mathews [16] suggested that chemical stability of var- 
io:is RS-NOs in vitro did not correlate with their depressor 
eflsct in vivo. 
ln contrast to the short lifetime of NO, RS-NO is fairly 
stz ble. For example, under physiological conditions, half-lives 
of GS-NO and S-nitroso-albumin in vitro are longer than 10 
h, while that of S-nitroso-cysteine is about 90 min [17]. Since 
gh ttathione S-conjugates are degraded to their constituent 
amino acids and the corresponding cysteine S-conjugates by 
y-plutamyltransferase and peptidases [18], the fate and biolog- 
ic;! 1 function of GS-NO might be affected by its metabolism in 
vi\ o. Since sodium borohydride has been used for releasing 
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NO from RS-NO [19], other molecules with reducing activity 
may also affect the fate of RS-NO in vivo. It has been well 
documented that ascorbic acid and GSH are the naturally 
occurring major reducing compounds (N 10 mM in cytosol 
and N 80 pM in plasma) [l&20]. The present work describes 
the reactivity of GS-NO with ascorbic acid. 
2. Materials and methods 
2. I. Materials 
GSH, 5,5’-dithiobis(2-nitrobenzoic acid) (DTNB), sodium nitrite 
and ascorbic acid were obtained from Wako Co. (Osaka, Japan). 
Diethylenetriamine-N,N,N’,N”,N”-pentaacetic acid (DETAPAC) was 
obtained from Dojin Chemical Co. (Kumamoto, Japan). Dehydroas- 
corbic acid was obtained by oxidizing ascorbic acid in 20 mM phos- 
phate buffer (pH 7.5) at 37°C for 5 days under an air stream. The 
oxidized sample contained no detectable level of the reduced form of 
ascorbic acid as detected by HPLC-electrochemical detection [21]. GS- 
NO was synthesized as reported by Saville [22]. Briefly, GSH was 
reacted with equimolar sodium nitrite in acidic medium (pH 2.0). 
After standing for 15 min at 25”C, 1 N NaOH was added to the 
reaction mixture to give a final pH of 7.5. To the mixture was added 
Tris-HCl buffer (pH 7.5) to give a final concentration of 20 mM. The 
extent of GS-NO formed was determined spectrophotometrically at 
545 nm [23]. Disappearance of GSH and nitrite in the reaction mix- 
ture was- confirmed by the methods of Ellman [24] and Green [25], 
resnectivelv. The vield of GS-NO generated from GSH was hieher 
than 96%.-All other reagents were of the highest grade commercyally 
available. 
2.2. Measurement of GS-NO and glutathione 
The concentration of GS-NO was determined spectrophotometri- 
tally as described previously [23] (~54s = 13.0 M-’ cm-‘) and by the 
method of Saville [22]. Total glutathione (GSH +2 GSSG) was meas- 
ured by the method of Tietze [26]. Free sulfhydryl group was deter- 
mined by using DTNB as described previously [24]. 
2.3. Measurement of nitrite and nitrate 
The amount of NO formed from RS-NO was determined as nitrite 
plus nitrate (NOx-). Nitrate in the reaction mixture was reduced to 
nitrite by the cadmium column method [25]. Nitrite was measured by 
the method of Griess [27]. 
2.4. Electron spin resonance (ESR) measurement 
The reaction mixture contained, in a final volume of 0.2 ml, 20 mM 
phosphate buffer (pH 7.5), 10 FM DETAPAC, 10 mM ascorbic acid 
and/or GS-NO. The reaction was started bv adding GS-NO. The ESR 
spectrum for monodehydroascorbate was recorded in a flat cell using 
JEOL TES-TEZOO at 37°C 12 mW power, 0.1 mT modulation, 335 
mT magnetic field strength, 100 mT scan range and time constant of 
0.3 s. 
3. Results 
Fig. la shows the disappearance of GS-NO under air atmo- 
spheric conditions at 37°C and pH 7.5 in the presence or 
absence of various concentrations of ascorbic acid. In the 
absence of ascorbic acid, GS-NO disappeared from the incu- 
bation mixture extremely slowly: the half-life of GS-NO was 
longer than 10 h. In the presence of ascorbic acid, however, 
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Fig. 1. Effect of ascorbic acid on S-nitroso-glutathione. The incubation mixture contained, in a final volume of 1 ml, 20 mM phosphate buffer 
(pH 7.9, 10 uM DETAPAC, 20 mM (a) or 50 uM (b) GS-NO and varying concentrations of ascorbic acid. The reaction was started by add- 
ing ascorbate at 37°C. In some experiments, the mixture contained either 20 mM of dehydroascorbate (0) or 7 mM GSH (A). The concentra- 
tions of ascorbic acid used were 0 (o), 7 (A), 20 (m) and 200 (0) mM for (a) and 0 (o), 50 (w) and 100 (0) uM for (b). 
GS-NO rapidly disappeared from the incubation mixture. The 
rate of GS-NO disappearance depended on the concentration 
of ascorbic acid. In contrast, incubation with dehydroascorbic 
acid had no effect on the rate of GS-NO disappearance. These 
results indicate that GS-NO reacted with ascorbic acid. In the 
presence of excess amounts of ascorbic acid, GS-NO disap- 
peared with a first-order rate constant of 1.02X lop2 s-l. GS- 
NO also reacted with GSH though the reactivity with this 
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Fig. 2. Stoichiometric reaction of GS-NO and ascorbic acid. The in- 
cubation mixture contained, in a final volume of 1 ml, 20 mM 
phosphate buffer (pH 7.5), 10 PM DETAPAC, 40 mM GS-NO and 
varying concentrations of ascorbic acid. After incubation at 37°C 
for 60 min in air, the reaction mixture was rapidly cooled to 0°C. 
Then, the concentration of GS-NO consumed was determined spec- 
trophotometrically. 
thiol was significantly lower than that with ascorbic acid. 
Fig. lb also shows the disappearance of GS-NO in the pres- 
ence of low concentrations of ascorbic acid. GS-NO also dis- 
appeared rapidly in the presence of physiologically low levels 
of ascorbic acid. 
Fig. 2 shows the amount of GS-NO disappearing in the 
presence of various concentrations of ascorbic acid. These 
results show that one mol of GS-NO disappeared at the ex- 
pense of 0.5 mol of ascorbic acid, indicating that the stoichio- 
metry of ascorbic acid to GS-NO is 2. Table 1 summarizes the 
reaction products formed upon incubation of GS-NO and 
ascorbate. GS-NO disappeared with the concomitant appear- 
ance of glutathione. After incubation for 60 min at 37”C, no 
DTNB-titratable thiol was found in the mixture. At the same 
time, the nitrous moiety of GS-NO was recovered as nitrite 
and nitrate (NOx-); the recovery of NOx- was about 80% of 
the GS-NO decomposed. 
Fig. 3 shows the ESR spectra for GS-NO and ascorbic acid. 
GS-NO itself showed no ESR signal (Fig. 3a). In contrast, 
ascorbic acid revealed a small signal caused by the presence 
of monodehydroascorbate (Fig. 3b). In the presence of both 
GS-NO and ascorbic acid, the ESR signal for monodehy- 
droascorbate increased markedly (Fig. 3~). Monodehydroas- 
corbate increased immediately after mixing GS-NO with as- 
corbic acid. The signal slowly decreased during the incubation 
with concomitant formation of glutathione (data not shown). 
These observations suggested the formation of monodehy- 
droascorbate as an intermediate during the reaction of GS- 
NO and ascorbic acid. 
4. Discussion 
The present work demonstrates that ascorbic acid and GS- 
NO stoichiometrically reacted and generated glutathione and 
NOx-, oxidized products of NO. One mol of ascorbic acid 
reacted with two mol of GS-NO with concomitant formation 
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Fik. 3. ESR spectrum for GS-NO, ascorbic acid and their mixtures. 
Th: reaction mixture contained, in a final volume of 0.2 ml, 20 mM 
phosphate buffer (pH 7.5), 10 pM DETAPAC and 10 mM GS-NO 
(a, ~4). The reaction was started by adding ascorbic acid. After in- 
cuhation for 1 (c), 22 (d) and 40 min (e), the ESR signals were ob- 
tained in the absence (a) or presence (be) of 10 mM ascorbic acid. 
Otiler conditions were as described for Fig. 1. 
of monodehydroascorbate and NOx-. When Ellman’s reagent 
(1 TIM) was added to the reaction mixture, chemical reduction 
of this reagent occurred during the incubation (data not 
shown). This observation might suggest the formation of a 
fre: sulfhydryl group as an unstable intermediate. Thus, the 
following reaction might have occurred during the incuba- 
tie ‘1: 
asI orbit acid + GS-NO + 
nonodehydroascorbate + GSH + NO 
ml nodehydroascorbate + GS-NO + 
Lehydroascorbate + NO + GSH 
in the presence of oxygen, NO is easily oxidized to NOx- 
[4] In fact, after incubation for 60 min, about 80% of the NO 
mc’iety of GS-NO was recovered as NOx-. The remaining 
20’ 6 of the NO moiety would be metabolized to other com- 
po:md(s) than NOx-. In this context, nitrous oxide has been 
kn,)wn to appear during the reaction of NO and GSH [6,28]. 
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Thus, nitrous oxide might possibly be formed during the in- 
cubation of GS-NO and ascorbic acid. 
Steady-state levels of NO in and around cells which have 
NO synthase would be fairly high. For example, endothelial 
cells of the aorta generate NO at a rate of -0.5 nmollminlg 
tissue [29]. In the presence of oxygen, NO is rapidly converted 
to Nz03 at a rate constant of 7X lo6 M-* s-l which then 
reacts with thiols to form RS-NO [7]. Since the intracellular 
level of GSH is as high as - 10 mM [18], significant fractions 
of NO would react with the SH group of this tripeptide. 
Assuming that NO exclusively reacted with GSH to form 
GS-NO, about 0.5 nmol/min of GS-NO might theoretically 
occur in and around 1 g of arterial walls. Intracellular con- 
centrations of ascorbic acid are also high (- 10 mM) [20]. 
Since GS-NO and ascorbic acid reacted stoichiometrically 
and form monodehydroascorbate as intermediary metabolite, 
this radical species would also occur in and around vascular 
walls. In fact, fairly high concentrations of monodehydroas- 
corbate occurred in the circulation of normal rats [30,31]. It 
has been suggested that ascorbic acid also reacts with vitamin 
E radical on cell surface membranes [32]. Thus, interactions of 
ascorbic acid with vitamin E radical and RS-NO might under- 
lie the mechanism for the formation of ascorbyl radical in 
vivo [30,31]. 
It has been reported that various thiols, such as GSH and 
cysteine, also react with RS-NO [22,33]. Thus, the lifetime of 
GS-NO would be fairly short in cells which are enriched with 
ascorbic acid and GSH. In contrast, plasma levels of ascorbic 
acid (40-80 l.tM) and GSH (5-25 PM) are significantly lower 
than those in cells (- 10 mM). Therefore, the lifetime of GS- 
NO in the circulation would be longer in plasma than in cells. 
In animals with septicemia, NO synthase (iNOS) is induced 
in the liver and other organs and, hence, significant amounts 
of NO (and GS-NO) would be generated in these tissues. 
Thus, the formation and degradation of GS-NO would be 
enhanced in endotoxemic subjects. Since plasma levels of as- 
corbic acid are fairly low, they might also be affected by the 
occurrence of GS-NO. In fact, plasma levels of ascorbic acid 
have been reported to decrease in lipopolysaccharide (LPS)- 
treated animals in which NO generation is significantly en- 
hanced by iNOS [34]. Active oxygen species formed in various 
cells and tissues which were challenged with oxidative stress 
also react with ascorbic acid thereby decreasing its plasma 
levels. The enhanced production of both GS-NO and active 
oxygen species might decrease plasma levels of ascorbic acid 
in vivo. Thus, levels and redox status of ascorbic acid might 
principally determine the fate and function of GS-NO and 
related nitroso-thiols. The pathophysiological significance of 
Taijle 1 
Re.lction products from Snitroso-glutathione and ascorbic acid 
Bet .,re After incubation 
GS NO Ascorbic acid GS-NO Ascorbic acid NOx- Glutathione SH 
(m-1 (mM) (mM) (mM) (mM) @Ml (mM) 
40 0 38 f 2.3 n.d. 1.3kO.3 2.8 f 0.4 n.d. 
40 20 n.d. n.d. 34 f 2.5 42 f 4.0 n.d. 
40 40 n.d. 18k2 33f 1.5 40 + 2.6 n.d. 
0 40 n.d. 38 Z! 0.9 n.d. n.d. n.d. 
Reaction mixtures contained, in a final volume of 1 ml, 20 mM phosphate buffer (pH 7.5), 10 PM DETAPAC, and varying concentrations of GS- 
NO and ascorbic acid. After incubation at 37°C for 60 min, the concentrations of various products were determined. Other conditions were as 
described in the text. Glutathione, GSH+2 GSSG; n.d., not detectable. 
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the interaction of RS-NO and ascorbic acid should be studied 
further. 
Acknowkdgement~e thank Drs. T. Yoshimura and 0. Pechanova for 
helpful suggestions. This work was supported by the Japan Heart 
Foundation and the Osaka Citv Universitv Medical Research Foun- 
dation Fund for Medical Research. . 
References 
;;; 
[31 
141 
[51 
161 
171 
PI 
191 
1101 
Ull 
WI 
1131 
Furchgott, R.F. and Zawadzki, J.V. (1980) Nature 288, 373-375. 
Lancaster, J.R. and Hibbs, J.B. (1990) Proc. Natl. Acad. Sci. 
USA 87, 1223-1227. 
Wink, D.A., Darbyshire, J.F., Nims, R.W., Saavedra, J. E. and 
Ford, P.C. (1993) Chem. Res. Toxicol. 6, 23-27. 
Ignarro, L.J., Fukuto, J.M., Griscavage, J.M., Rogers, N. E. and 
Byms, R.L. (1993) Proc. Natl. Acad. Sci. USA 90, 8103-8107. 
Beckman, J.S. (1990) Proc. Natl. Acad. Sci. USA 87, 1620-1624. 
DeMaster, E.G., Quast, B.J., Redfern, B. and Nagasawa, H.T. 
(1995) Biochemistry 34, 11494-l 1499. 
Kharitonov, V.G., Sundquist, A.R. and Sharma, V.S. (1995) 
J. Biol. Chem. 270, 28158-28164. 
Stamler, J.S., Jaraki, O., Osborne, J., Simon, D.L., Keaney, J., 
Vita, J., Singel, D., Valeri, C.R. and Loscalzo, J. (1992) Proc. 
Natl. Acad. Sci. USA 89, 7674-7677. 
Gaston, B., Reilly, J., Drazen, J.M., Fackler, J., Ramdev, P., 
Amelle, D., Mullins, M.E., Sugarbaker, D.J., Chee, C., Signal, 
D.J., Loscalzo, J. and Stamler, J. (1993) Proc. Natl. Acad. Sci. 
USA 90, 10957-10961. 
Keaney, J.F., Simon, D.I., Stamler, J.S., Jaraki, O., Scharfstein, 
J., Vita, J.A. and Loscalzo, J. (1993) J. Clin. Invest. 91, 1582- 
1589. 
Ignarro, L.J., Edwards, J.C., Greutter, D.Y., Barry, B. K. and 
Greutter, C.A. (1980) FEBS Lett. 11, 2755278. 
Ignarro, L.J., Lipton, H., Edwards, J.C., Barricos, W.H., Hy- 
man. A.L.. Kadowiz. P.J. and Greutter. C.A. (1981) J. Pharma- 
col. Exp. Ther. 218, 739-749. 
_ 
Myers, P.R., Minor, R.L., Guerra, R., Bates, J.N. and Harrison, 
D.G. (1990) Nature 345, 161-163. 
M. Kashiba-Iwatsuki et al.IFEBS Letters 389 (1996) 149-152 
[14] Ignarro, L.J. (1992) Biochem. Sot. Trans. 20, 81&811. 
[15] Craven. P.A. and DeRubertis. F.R. (1983) Biochim. Biouhvs. 
V61 
P71 
[I81 
u91 
Acta 745, 31&321. 
\ I . < 
Mathews, W.R. and Kerr, S.W. (1993) J. Pharmacol. Exp. Ther. 
267, 1529-1537. 
Arnelle, D.R. and Stamler, J.S. (1995) Arch. Biochem. Biophys. 
318, 279-285. 
Inoue, M. (1985) in: Renal Biochemistry Cells, Membranes, Mol- 
ecules (Kinne, R.K.H., Ed.) pp. 225-269. Elsevier, Amsterdam. 
Clancy, R.M., Levartovsky, D., Leszczynska-Piziak, J., Yegudin, 
J. and Abramson, S.B. (1994) Proc. Natl. Acad. Sci. USA 91, 
3680-3684. 
[201 
1211 
P21 
1231 
1241 
1251 
VI 
~271 
WI 
1291 
1301 
1311 
1321 
[331 
[341 
Hornig, D. (1975) Ann. NY Acad. Sci. 258, 103-118. 
Iwatsuki, M., Niki, E. and Kato, S. (1993) BioFactors 4, 1233 
128. 
Saville, B. (1958) Analyst 83, 670-672. 
Park, J.-W. (1988) Biochem. Biophys. Res. Commun. 152, 916 
920. 
Ellman, G.L. (1959) Arch. Biochem. Biophys. 82, 70-77. 
Green, L.C., Wagner, D.A., Glogowski, J., Skipper, P. L., Wish- 
nok, J.S. and Tannenbaum, S.R. (1982) Anal. Biochem. 126, 
131-138. 
Tietze, F. (1969) Anal. Biochem. 27, 5022522. 
Griess, J.P. (1879) Ber. Deutsch. Chem. Ges. 12, 426. 
Pryor, W.A., Church, D.F., Govindan, C.K. and Crack, G. 
(1982) J. Org. Chem. 47, 156159. 
Salter, M., Knowles, R.G. and Moncada, S. (1991) FEBS Lett. 
291, 1455149. 
Koyama, K., Takatsuki, K. and Inoue, M. (1994) Arch. Bio- 
them. Biophys. 309, 323-328. 
Kunitomo. R.. Mivauchi. Y. and Inoue. M. (1991) J. Biol. Chem. 
267, 8732-8738. z 
\ I 
Niki, E., Saito, T., Kawakami, A. and Kamiya, Y. (1984) J. Biol. 
Chem. 259, 41774182. 
Pietraforte. D.. Mallozzi. C.. Scorza. G. and Minetti. M. (1995) 
Biochemistry 34, 7177-7185.’ ’ 
, \ , 
Yamaguchi, T., Horio, F., Hashizumi, T., Tanaka, M., Ikeda, S., 
Kakinuma, A. and Nakajima, H. (1995) Biochem. Biophys. Res. 
Commun. 214, 11-19. 
